Precision medicine

Kenneth Y Tsai1

  • 1Departments of Dermatology & Immunology, MD Anderson Cancer Center, University of Texas Health Sciences Center Houston, Houston, TX USA.

Insights

Precision medicine, tailoring treatments to individual patients, is becoming more prevalent, especially in cancer care. This approach enhances diagnostic, therapeutic, and monitoring strategies for personalized patient outcomes.

Area of Science:

  • Oncology
  • Personalized Medicine
  • Translational Science

Background:

  • The increasing prevalence of personalized diagnostic, therapeutic, and monitoring strategies marks a significant shift in medical practice.
  • Oncology serves as a leading field demonstrating the successful implementation of these tailored patient approaches.

Discussion:

  • Discussing the integration of individualized patient data into clinical decision-making.
  • Highlighting the impact of precision medicine on treatment efficacy and patient monitoring.
  • Examining the challenges and opportunities in scaling personalized healthcare strategies.

Key Insights:

  • Patient-tailored strategies are revolutionizing healthcare delivery.
  • Oncology is at the forefront of adopting personalized diagnostic and therapeutic interventions.
  • Effective monitoring is crucial for optimizing individualized treatment plans.

Outlook:

  • Future advancements will likely focus on further refining personalized medicine through data analytics and novel biomarkers.
  • Expansion of precision medicine into other therapeutic areas beyond oncology is anticipated.
  • The ongoing evolution of healthcare necessitates adaptive and individualized patient care models.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
246
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
156